IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.603
-0.007 (-1.20%)
At close: Nov 20, 2024, 4:00 PM
0.591
-0.011 (-1.86%)
Pre-market: Nov 21, 2024, 7:15 AM EST
IceCure Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 3.34 | 3.23 | 3.09 | 4.14 | 3.87 | 5.74 | |
| Revenue Growth (YoY) | 3.60% | 4.67% | -25.45% | 6.98% | -32.61% | 42.18% | |
| Cost of Revenue | 1.99 | 1.93 | 1.64 | 1.94 | 1.42 | 3.74 | |
| Gross Profit | 1.35 | 1.3 | 1.45 | 2.2 | 2.44 | 2 | |
| Selling, General & Admin | 8.14 | 8.6 | 9.06 | 6.04 | 2.78 | 8.1 | |
| Research & Development | 7.62 | 8.27 | 9.12 | 5.88 | 3.81 | 9.86 | |
| Operating Expenses | 15.76 | 16.88 | 18.18 | 11.92 | 6.59 | 17.96 | |
| Operating Income | -14.42 | -15.58 | -16.74 | -9.72 | -4.14 | -15.96 | |
| Interest Expense | - | - | -0.24 | -0.17 | - | -0.08 | |
| Interest & Investment Income | 0.73 | 0.92 | - | - | 0.41 | - | |
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.13 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | -0.62 | |
| Pretax Income | -13.69 | -14.65 | -16.98 | -9.9 | -3.73 | -16.53 | |
| Net Income | -13.69 | -14.65 | -16.98 | -9.9 | -3.73 | -16.53 | |
| Net Income to Common | -13.69 | -14.65 | -16.98 | -9.9 | -3.73 | -16.53 | |
| Shares Outstanding (Basic) | 47 | 46 | 37 | 29 | 17 | 14 | |
| Shares Outstanding (Diluted) | 47 | 46 | 37 | 29 | 17 | 14 | |
| Shares Change (YoY) | 12.87% | 23.29% | 29.66% | 66.67% | 25.75% | 16.74% | |
| EPS (Basic) | -0.29 | -0.32 | -0.46 | -0.35 | -0.22 | -1.21 | |
| EPS (Diluted) | -0.29 | -0.32 | -0.46 | -0.35 | -0.22 | -1.21 | |
| Free Cash Flow | -11.02 | -13 | -15.18 | -13.14 | -3.91 | -6.39 | |
| Free Cash Flow Per Share | -0.24 | -0.28 | -0.41 | -0.46 | -0.23 | -0.47 | |
| Gross Margin | 40.32% | 40.26% | 46.84% | 53.04% | 63.19% | 34.77% | |
| Operating Margin | -432.13% | -482.38% | -542.59% | -234.99% | -107.08% | -278.03% | |
| Profit Margin | -410.22% | -453.76% | -550.34% | -239.13% | -96.43% | -288.00% | |
| Free Cash Flow Margin | -330.34% | -402.63% | -492.16% | -317.50% | -101.16% | -111.25% | |
| EBITDA | -14.08 | -15.25 | -16.49 | -9.6 | -4.08 | -15.86 | |
| EBITDA Margin | - | - | - | -231.92% | -105.45% | -276.24% | |
| D&A For EBITDA | 0.33 | 0.32 | 0.25 | 0.13 | 0.06 | 0.1 | |
| EBIT | -14.42 | -15.58 | -16.74 | -9.72 | -4.14 | -15.96 | |
| EBIT Margin | - | - | - | -234.99% | -107.08% | -278.03% | |
| Advertising Expenses | - | 0.09 | 0.07 | 0.06 | 0.04 | 0.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.